We work with the world's best.

Performs our Comprehensive Tumor Profiling and Liquid Biopsy testing — a global leader in molecular profiling, used in over 4 million patient cases worldwide.

Performs the Breast Cancer Index — the only test that predicts late distant recurrence in HR+ breast cancer and guides extended endocrine therapy.

Performs the 4Kscore prostate cancer risk test — a blood-based assay that estimates the probability of aggressive prostate cancer before biopsy.

Performs our Hereditary Cancer Risk panels — germline testing across all major cancer predisposition genes.

Performs MRD Monitoring with the Signatera assay — tumor-informed detection of minimal residual disease after treatment.